657 related articles for article (PubMed ID: 28246104)
1. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
2. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes.
Seok YM; Yoo JM; Nam Y; Kim J; Kim JS; Son JH; Kim HJ
J Ethnopharmacol; 2021 Apr; 270():113557. PubMed ID: 33161026
[TBL] [Abstract][Full Text] [Related]
3. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
4. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
[TBL] [Abstract][Full Text] [Related]
5. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
6. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J
PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964
[TBL] [Abstract][Full Text] [Related]
8. Oligonol, a Low-Molecular Weight Polyphenol Derived from Lychee, Alleviates Muscle Loss in Diabetes by Suppressing Atrogin-1 and MuRF1.
Liu HW; Chen YJ; Chang YC; Chang SJ
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28930190
[TBL] [Abstract][Full Text] [Related]
9. Conessine Treatment Reduces Dexamethasone-Induced Muscle Atrophy by Regulating MuRF1 and Atrogin-1 Expression.
Kim H; Jang M; Park R; Jo D; Choi I; Choe J; Oh WK; Park J
J Microbiol Biotechnol; 2018 Apr; 28(4):520-526. PubMed ID: 29724080
[TBL] [Abstract][Full Text] [Related]
10. Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I.
Lang CH; Huber D; Frost RA
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R328-36. PubMed ID: 16946078
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
[TBL] [Abstract][Full Text] [Related]
12. An extract of Artemisia dracunculus L. inhibits ubiquitin-proteasome activity and preserves skeletal muscle mass in a murine model of diabetes.
Kirk-Ballard H; Wang ZQ; Acharya P; Zhang XH; Yu Y; Kilroy G; Ribnicky D; Cefalu WT; Floyd ZE
PLoS One; 2013; 8(2):e57112. PubMed ID: 23437325
[TBL] [Abstract][Full Text] [Related]
13. 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy
Wang M; Jiang R; Liu J; Xu X; Sun G; Zhao D; Sun L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649814
[TBL] [Abstract][Full Text] [Related]
14. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
[TBL] [Abstract][Full Text] [Related]
15. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Ligustrazine on expressions of FoXO3a, MAFbx, and MuRF1 in denervated skeletal muscle atrophy rats].
Wang H; Liang B; Peng C; Wang P
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 May; 26(5):597-600. PubMed ID: 22702057
[TBL] [Abstract][Full Text] [Related]
19. Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo.
Pires-Oliveira M; Maragno AL; Parreiras-e-Silva LT; Chiavegatti T; Gomes MD; Godinho RO
J Appl Physiol (1985); 2010 Feb; 108(2):266-73. PubMed ID: 19926828
[TBL] [Abstract][Full Text] [Related]
20. l-Carnitine supplement reduces skeletal muscle atrophy induced by prolonged hindlimb suspension in rats.
Jang J; Park J; Chang H; Lim K
Appl Physiol Nutr Metab; 2016 Dec; 41(12):1240-1247. PubMed ID: 27841025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]